无创骨转换标志物诊断肾性骨营养不良的准确性
结果显示AUC在0.75-0.85之间,高/低骨转换的阴性预测值均≥90%,联合标志物诊断准确性高转换90%、低转换78%。结论认为生化标志物可用于排除高和低骨转换骨病。
要点
- 骨活检仍是肾性骨营养不良诊断金标准。
- 生物标志物AUC 0.75-0.85,阴性预测值≥90%。
- 联合标志物诊断准确性高转换90%、低转换78%。
核心结论
- 骨转换生化标志物的诊断性能可接受,临床可用于排除高和低骨转换骨病。
研究设计与样本
- 横断面回顾性诊断试验,纳入CKD GFR分期4-5(含透析)及肾移植受者,探索组n=100,验证组n=99。
主要发现
- 低、正常、高骨转换分别为33例(17%)、109例(55%)、57例(29%)。
- 所有标志物在不同骨转换类别间均有差异,AUC范围0.75-0.85。
- 高和低骨转换的阴性预测值均≥90%。
- 联合标志物总体诊断准确性高转换90%、低转换78%。
- 敏感性分析中肾移植候选者与受者结果相当。
关键数值与推荐
- 诊断性能评估指标包括AUC、敏感性、特异性、阴性及阳性预测值。
- 最佳诊断切点在探索组(n=100)确定并在验证组(n=99)验证。
临床怎么用
- 可使用生物标志物(如biointact PTH、BsAP、PINP、TRAP5b)及其联合来排除高或低骨转换骨病。
局限性
- 单中心设计。
- 研究队列存在异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Bone biopsy remains the gold standard for diagnosing renal osteodystrophy as comparable noninvasive alternatives have yet to be established. This study investigated the diagnostic accuracy of biochemical markers of skeletal remodeling to predict bone turnover. STUDY DESIGN: Cross-sectional retrospective diagnostic test study. SETTING & PARTICIPANTS: Patients with chronic kidney disease glomerular filtration rate categories 4-5, including patients treated with dialysis (G4-G5D) and kidney transplant recipients with successful transiliac bone biopsies. TESTS COMPARED: Bone turnover as determined by bone histomorphometry was compared with the following biochemical markers: full-length (amino acids 1-84) "biointact" parathyroid hormone (PTH), bone-specific alkaline phosphatase (BsAP), intact procollagen type I N-terminal propeptide (PINP), and tartrate-resistant acid phosphatase isoform 5b (TRAP5b). OUTCOME: Diagnostic performance was evaluated by area under the receiver operator characteristics curve (AUC), sensitivity, specificity, and negative and positive predictive values. Optimal diagnostic cutoffs were determined in an exploration cohort (n = 100) and validated in a separate cohort (n = 99). RESULTS: All biomarkers differed across categories of low 33 (17%), normal 109 (55%), and high 57 (29%) bone turnover. AUC values were in the range of 0.75-0.85. High negative predictive values (≥90%) were found for both high and low bone turnover, indicating the ability to rule out both conditions using the suggested biomarker cutoffs. The highest diagnostic performances were seen with combinations of biomarkers, with overall diagnostic accuracies of 90% for high turnover, and 78% for low turnover. Results were comparable for kidney transplant candidates and recipients in a sensitivity analysis. LIMITATIONS: The single-center approach and heterogeneity of the study cohort are main limitations of this study. CONCLUSIONS: We conclude that the diagnostic performance of biochemical markers of bone turnover is acceptable, with clinical utility in ruling out both high and low turnover bone disease.
引用
- Jørgensen HS, Behets G, Viaene L, et al. Diagnostic Accuracy of Noninvasive Bone Turnover Markers in Renal Osteodystrophy. Am J Kidney Dis. 2021. PMID: 34710517. doi:10.1053/j.ajkd.2021.07.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。